v3.26.1
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
A summary of the stock option activity is as follows:
Number of
options
Weighted
average
exercise
price
Weighted
average
remaining
contractual
life
Aggregate
intrinsic
value
(In thousands)(In years)(In thousands)
Balance as of December 31, 202515,170 $4.02 3.99$14,414 
Exercised(110)$0.87 
 
$147 
Canceled(566)$12.88 
 
 
Balance as of June 30, 202614,494 $3.70 3.55$3,050 
Vested and exercisable as of June 30, 202614,093 $3.74 3.55$3,050 
Schedule of RSU and PSU Activity
A summary of the Company’s RSU activity and related information is as follows:
Number of RSUs
Weighted
average
grant date fair value per share
(In thousands)
Balance as of December 31, 202512,739 $2.84 
Granted6,334 $1.74 
Vested(3,879)$2.34 
Forfeited
(826)$2.58 
Balance as of June 30, 202614,368 $2.51 
A summary of the Company’s PSU activity and related information is as follows:
Number of PSUs
Weighted
average
grant date fair value per share
(In thousands)
Balance as of December 31, 20257,260 $2.06 
Granted992 $0.45 
Canceled and forfeited
(625)$0.64 
Balance as of June 30, 20267,627 $1.97 
Schedule of Valuation Assumptions
The estimated weighted-average grant date fair value of the awards issued during the first quarter of 2026 was $0.45 per share, which was determined using a Monte Carlo simulation model. The significant assumptions in the Monte Carlo simulation model include the risk-free interest rate, expected volatility of the Company’s stock price, and expected life of the award.

Fair value of common stock
$1.75
Remaining contractual term (years)
3.87
Expected volatility
90%
Risk-free interest rate
3.57%
Expected dividend yield
—
The remaining tranches were valued using a Monte Carlo simulation model. The weighted average estimated fair value of the remaining tranches was $3.80 per share based on the following assumptions:
Fair value of common stock$18.00
Remaining contractual term (years)14.75
Expected volatility40.00%
Risk-free interest rate1.71%
Expected dividend yield—
Schedule of Stock-Based Compensation Expense
The Company’s stock-based compensation expense was as follows:

Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
(In thousands)(In thousands)
Cost of revenue$146 $116 $268 $286 
Research and development(1)
1,496 1,272 3,157 2,956 
Sales and marketing794 618 1,076 1,338 
General and administrative4,542 5,576 9,257 9,098 
Total$6,978$7,582$13,758$13,678
____________
(1) Net of $0.1 million and $0.2 million of additions to capitalized internal-use software for the three and six months ended June 30, 2026 and $1.1 million and $2.3 million for the three and six months ended June 30, 2025.